# OnCo record omniseq-insight (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/omniseq-insight/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "omniseq-insight" ;
  schema:name "OmniSeq INSIGHT"@en ;
  schema:alternateName "Labcorp OmniSeq INSIGHT"@en, "OmniSeq INSIGHT Genomic Profiling Assay"@en, "OmniSeq INSIGHT" ;
  schema:description "Labcorp's tissue gene test for solid tumours, covering 523 genes with a 7 to 10 day turnaround and an option to add PD-L1 testing on the same sample."@en ;
  schema:url <https://onco.cc/drugs/omniseq-insight/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.labcorp.com/oncology/providers/testing-solutions/solid-tumor>, <https://www.labcorp.com/oncology/biopharma/portfolio/solid-tissue-profiling/omniseq-insight-genomic> ;
  onco:status "established" ;
  onco:tag "test" ;
  onco:modality "Tissue comprehensive genomic profiling test (DNA and RNA sequencing)" ;
  onco:related <https://onco.cc/biomarkers/pd-l1-cps/>, <https://onco.cc/biomarkers/pd-l1-tps/>, <https://onco.cc/biomarkers/msi-high/>, <https://onco.cc/biomarkers/tmb-high/> ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:technologies <https://onco.cc/technologies/cgp/>, <https://onco.cc/technologies/reference-laboratories/> ;
  onco:companies <https://onco.cc/companies/labcorp/> ;
  onco:terms <https://onco.cc/terms/ngs/>, <https://onco.cc/terms/tmb/>, <https://onco.cc/terms/msi/>, <https://onco.cc/terms/hrd/> .